Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation-an observational study including 2044 patients.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of clinical pharmacology"
DOI: 10.1007/s00228-020-03002-y
Abstract: PURPOSE Zuclopenthixol is an antipsychotic available as oral and long-acting injectable (LAI) formulations. The aim of this study was to investigate the effect of age on zuclopenthixol exposure during oral and LAI administrations without and… read more here.
Keywords: exposure; zuclopenthixol; cyp2d6 genotype; study ... See more keywords